Description
There are no published studies documenting outcomes with the use of eravacycline against drug-resistant Acinetobacter baumannii. The purpose of this study is to assess the efficacy of eravacycline use, in comparison to best previously available therapy, in patients with drug-resistant Acinetobacter baumannii pneumonia.
Disciplines
Clinical Trials | Health and Medical Administration | Health and Physical Education | Health Services Research | Medical Education | Medical Sciences | Medicine and Health Sciences | Primary Care
Recommended Citation
Scott, Courtney Jane; Jayakumar, Rebecca; Zhu, Elizabeth; and Viswesh, Velliyur, "C22: Eravacycline versus best previously available therapy in adults with pneumonia due to drug-resistant Acinetobacter baumannii" (2021). Annual Research Symposium. 17.
https://ecommons.roseman.edu/researchsymposium/2021/postergroup4/17